Back to Search
JACOB SEYMOUR, D.O.
D.O.
Rheumatology Physician
NPI: 1396139283IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Rheumatology PhysicianPrimary
Internal Medicine — Rheumatology
Code: 207RR0500X
34.014442(OH)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
LAKE ERIE COLLEGE OF OSTEOPATHIC MEDICINE, ERIE
Class of 2015
Research & Publications (20)
The frequency, manifestations, and duration of prolonged cytopenias after first-line fludarabine combination chemotherapy.
PMID 19625344·Ann Oncol·2010
8-other
Ultrasound measurement of rectus femoris cross-sectional area and the relationship with quadriceps strength in COPD.
PMID 19158125·Thorax·2009
8-other
Extra-pulmonary aspects of acquired pulmonary alveolar proteinosis as predicted by granulocyte-macrophage colony-stimulating factor-deficient mice.
PMID 16423263·Respirology·2006
6-review
Shedding new light onto the ceiling and floor? A quantile regression approach to compare EQ-5D and SF-6D responses.
PMID 19504545·Health Econ·2010
8-other
Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal Lymphoma Study Group.
PMID 19570964·Ann Oncol·2009
8-other
The BH3 mimetic compound, ABT-737, synergizes with a range of cytotoxic chemotherapy agents in chronic lymphocytic leukemia.
PMID 19641525·Leukemia·2009
8-other
Intralesional rituximab for the treatment of localised palatal relapse of follicular lymphoma.
PMID 19197721·Leuk Lymphoma·2009
5-case
An in vivo comparison of the efficacy of CSL box jellyfish antivenom with antibodies raised against nematocyst-derived Chironex fleckeri venom.
PMID 19429250·Toxicol Lett·2009
4-observational
Impairment of peripheral blood stem-cell mobilisation in patients with mantle-cell lymphoma following primary treatment with fludarabine and cyclophosphamide +/- rituximab.
PMID 19197732·Leuk Lymphoma·2009
3-trial
In vivo evaluation of a neural stem cell-seeded prosthesis.
PMID 19287078·J Neural Eng·2009
7-preclinical
Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project.
PMID 19264918·Blood·2009
4-observational
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.
PMID 19230772·Lancet Oncol·2009
3-trial
Osteonecrosis of the jaw complicating bisphosphonate treatment for bone disease in multiple myeloma: an overview with recommendations for prevention and treatment.
PMID 19220531·Intern Med J·2009
6-review
Effect of a home exercise video programme in patients with chronic obstructive pulmonary disease.
PMID 19229454·J Rehabil Med·2009
2-rct
Key stakeholders' experiences and views of the NHS End of Life Care Programme: findings from a national evaluation.
PMID 19433472·Palliat Med·2009
8-other
Toxicity of fludarabine and cyclophosphamide with or without rituximab as initial therapy for patients with previously untreated mantle cell lymphoma: results of a randomised phase II study.
PMID 19197729·Leuk Lymphoma·2009
3-trial
Fludarabine combinations for patients with advanced marginal zone lymphomas--best treatment option or too toxic?
PMID 19638019·Br J Haematol·2009
8-other
Barriers to achieving care at home at the end of life: transferring patients between care settings using patient transport services.
PMID 19643950·Palliat Med·2009
4-observational
Fruit and vegetable intake among adolescents and adults in the United States: percentage meeting individualized recommendations.
PMID 19295947·Medscape J Med·2009
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1211 DUBLIN RD
COLUMBUS, OH 43215 - Phone
- (614) 486-5200
Quick Facts
- NPI
- 1396139283
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 11
- Publications
- 20
Are you this provider?
Claim Your Profile